AxoGen, Inc. (AXGN)
USD 16.14
(-5.28%)
USD 16.14
(-5.28%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 101.16 Million USD | 7.18% |
| 2022 | 94.38 Million USD | -1.14% |
| 2021 | 95.47 Million USD | 22.04% |
| 2020 | 78.23 Million USD | 247.85% |
| 2019 | 22.49 Million USD | 70.5% |
| 2018 | 13.19 Million USD | -60.85% |
| 2017 | 33.69 Million USD | 7.17% |
| 2016 | 31.43 Million USD | 7.12% |
| 2015 | 29.35 Million USD | 6.16% |
| 2014 | 27.64 Million USD | 0.36% |
| 2013 | 27.54 Million USD | 19.46% |
| 2012 | 23.06 Million USD | 258.99% |
| 2011 | 6.42 Million USD | 5517.51% |
| 2010 | 114.34 Thousand USD | -98.01% |
| 2009 | 5.74 Million USD | 2623.1% |
| 2008 | 211.05 Thousand USD | 4.91% |
| 2007 | 201.17 Thousand USD | -7.66% |
| 2006 | 217.87 Thousand USD | 35.44% |
| 2005 | 160.86 Thousand USD | -69.13% |
| 2004 | 521.05 Thousand USD | -81.68% |
| 2003 | 2.84 Million USD | -10.65% |
| 2002 | 3.18 Million USD | 13.29% |
| 2001 | 2.8 Million USD | -25.16% |
| 2000 | 3.75 Million USD | 44.41% |
| 1999 | 2.6 Million USD | 62.5% |
| 1998 | 1.6 Million USD | -46.67% |
| 1997 | 3 Million USD | 114.29% |
| 1996 | 1.4 Million USD | -6.67% |
| 1995 | 1.5 Million USD | -6.25% |
| 1994 | 1.6 Million USD | 128.57% |
| 1993 | 700 Thousand USD | 40.0% |
| 1992 | 500 Thousand USD | -28.57% |
| 1991 | 700 Thousand USD | -53.33% |
| 1990 | 1.5 Million USD | -11.76% |
| 1989 | 1.7 Million USD | 54.55% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 93.24 Million USD | -0.12% |
| 2024 Q1 | 93.36 Million USD | -7.71% |
| 2023 Q1 | 91.96 Million USD | -2.57% |
| 2023 Q4 | 101.16 Million USD | 4.48% |
| 2023 Q3 | 96.82 Million USD | 2.47% |
| 2023 FY | 101.16 Million USD | 7.18% |
| 2023 Q2 | 94.48 Million USD | 2.75% |
| 2022 FY | 94.38 Million USD | -1.14% |
| 2022 Q1 | 94.17 Million USD | -1.36% |
| 2022 Q4 | 94.38 Million USD | 0.33% |
| 2022 Q3 | 94.07 Million USD | -0.34% |
| 2022 Q2 | 94.39 Million USD | 0.23% |
| 2021 Q2 | 91.82 Million USD | 18.24% |
| 2021 Q4 | 95.47 Million USD | 0.83% |
| 2021 FY | 95.47 Million USD | 22.04% |
| 2021 Q1 | 77.66 Million USD | -0.72% |
| 2021 Q3 | 94.69 Million USD | 3.12% |
| 2020 FY | 78.23 Million USD | 247.85% |
| 2020 Q1 | 20.68 Million USD | -8.01% |
| 2020 Q2 | 50.2 Million USD | 142.65% |
| 2020 Q3 | 72.22 Million USD | 43.87% |
| 2020 Q4 | 78.23 Million USD | 8.32% |
| 2019 Q1 | 19.74 Million USD | 49.72% |
| 2019 Q2 | 18.64 Million USD | -5.6% |
| 2019 Q3 | 18.78 Million USD | 0.74% |
| 2019 Q4 | 22.49 Million USD | 19.75% |
| 2019 FY | 22.49 Million USD | 70.5% |
| 2018 Q4 | 13.19 Million USD | 8.32% |
| 2018 Q3 | 12.17 Million USD | 21.29% |
| 2018 Q2 | 10.04 Million USD | -70.01% |
| 2018 Q1 | 33.47 Million USD | -0.63% |
| 2018 FY | 13.19 Million USD | -60.85% |
| 2017 Q3 | 31.67 Million USD | 0.7% |
| 2017 FY | 33.69 Million USD | 7.17% |
| 2017 Q4 | 33.69 Million USD | 6.37% |
| 2017 Q2 | 31.45 Million USD | 0.99% |
| 2017 Q1 | 31.14 Million USD | -0.93% |
| 2016 Q3 | 29.66 Million USD | 2.46% |
| 2016 Q1 | 28.65 Million USD | -2.36% |
| 2016 FY | 31.43 Million USD | 7.12% |
| 2016 Q4 | 31.43 Million USD | 5.97% |
| 2016 Q2 | 28.95 Million USD | 1.05% |
| 2015 Q3 | 29.73 Million USD | 2.71% |
| 2015 Q2 | 28.95 Million USD | 0.48% |
| 2015 Q1 | 28.81 Million USD | 4.23% |
| 2015 FY | 29.35 Million USD | 6.16% |
| 2015 Q4 | 29.35 Million USD | -1.3% |
| 2014 FY | 27.64 Million USD | 0.36% |
| 2014 Q3 | 30.28 Million USD | 2.4% |
| 2014 Q2 | 29.57 Million USD | 4.65% |
| 2014 Q1 | 28.26 Million USD | 2.59% |
| 2014 Q4 | 27.64 Million USD | -8.71% |
| 2013 Q4 | 27.54 Million USD | 7.4% |
| 2013 Q3 | 25.64 Million USD | 2.72% |
| 2013 Q2 | 24.97 Million USD | 4.67% |
| 2013 Q1 | 23.85 Million USD | 3.46% |
| 2013 FY | 27.54 Million USD | 19.46% |
| 2012 FY | 23.06 Million USD | 258.99% |
| 2012 Q4 | 23.06 Million USD | 171.65% |
| 2012 Q3 | 8.48 Million USD | 29.26% |
| 2012 Q2 | 6.56 Million USD | 3.3% |
| 2012 Q1 | 6.35 Million USD | -1.04% |
| 2011 Q1 | 232.46 Thousand USD | 103.29% |
| 2011 Q2 | 611.57 Thousand USD | 163.09% |
| 2011 Q3 | 6.48 Million USD | 960.12% |
| 2011 Q4 | 6.42 Million USD | -0.92% |
| 2011 FY | 6.42 Million USD | 5517.51% |
| 2010 Q1 | 467.61 Thousand USD | -91.86% |
| 2010 FY | 114.34 Thousand USD | -98.01% |
| 2010 Q4 | 114.34 Thousand USD | -18.94% |
| 2010 Q3 | 141.06 Thousand USD | 3.01% |
| 2010 Q2 | 136.94 Thousand USD | -70.71% |
| 2009 Q2 | 416.88 Thousand USD | 61.8% |
| 2009 Q3 | 269.22 Thousand USD | -35.42% |
| 2009 Q4 | 5.74 Million USD | 2034.74% |
| 2009 FY | 5.74 Million USD | 2623.1% |
| 2009 Q1 | 257.65 Thousand USD | 22.08% |
| 2008 Q2 | 233.76 Thousand USD | -5.38% |
| 2008 Q4 | 211.05 Thousand USD | 1.54% |
| 2008 Q1 | 247.04 Thousand USD | 22.8% |
| 2008 FY | 211.05 Thousand USD | 4.91% |
| 2008 Q3 | 207.85 Thousand USD | -11.08% |
| 2007 Q4 | 201.17 Thousand USD | -6.02% |
| 2007 FY | 201.17 Thousand USD | -7.66% |
| 2007 Q1 | 252.34 Thousand USD | 15.82% |
| 2007 Q2 | 204.05 Thousand USD | -19.14% |
| 2007 Q3 | 214.06 Thousand USD | 4.9% |
| 2006 Q3 | 175.47 Thousand USD | -10.06% |
| 2006 Q4 | 217.87 Thousand USD | 24.16% |
| 2006 FY | 217.87 Thousand USD | 35.44% |
| 2006 Q2 | 195.1 Thousand USD | 9.44% |
| 2006 Q1 | 178.26 Thousand USD | 10.82% |
| 2005 FY | 160.86 Thousand USD | -69.13% |
| 2005 Q2 | 185.33 Thousand USD | -20.73% |
| 2005 Q3 | 224.87 Thousand USD | 21.34% |
| 2005 Q4 | 160.86 Thousand USD | -28.47% |
| 2005 Q1 | 233.8 Thousand USD | -55.13% |
| 2004 Q2 | 2.46 Million USD | -0.0% |
| 2004 FY | 521.05 Thousand USD | -81.68% |
| 2004 Q4 | 521.05 Thousand USD | -79.31% |
| 2004 Q3 | 2.51 Million USD | 2.13% |
| 2004 Q1 | 2.46 Million USD | -13.32% |
| 2003 FY | 2.84 Million USD | -10.65% |
| 2003 Q4 | 2.84 Million USD | 2.55% |
| 2003 Q1 | 2.29 Million USD | -27.96% |
| 2003 Q2 | 2.72 Million USD | 18.76% |
| 2003 Q3 | 2.77 Million USD | 1.84% |
| 2002 Q1 | 2.89 Million USD | 0.0% |
| 2002 Q2 | 3.23 Million USD | 11.75% |
| 2002 Q3 | 3.01 Million USD | -6.62% |
| 2002 Q4 | 3.18 Million USD | 5.51% |
| 2002 FY | 3.18 Million USD | 13.29% |
| 2001 Q2 | 3.88 Million USD | -18.87% |
| 2001 Q3 | 3.19 Million USD | -17.81% |
| 2001 FY | 2.8 Million USD | -25.16% |
| 2001 Q1 | 4.78 Million USD | -2.73% |
| 2000 Q4 | 4.91 Million USD | 19.61% |
| 2000 Q3 | 4.11 Million USD | 9.52% |
| 2000 Q2 | 3.75 Million USD | -4.77% |
| 2000 Q1 | 3.94 Million USD | 46.03% |
| 2000 FY | 3.75 Million USD | 44.41% |
| 1999 Q4 | 2.7 Million USD | 0.0% |
| 1999 Q1 | 2.3 Million USD | 4.55% |
| 1999 Q2 | 2.6 Million USD | 13.04% |
| 1999 Q3 | 2.7 Million USD | 3.85% |
| 1999 FY | 2.6 Million USD | 62.5% |
| 1998 Q3 | 1.9 Million USD | 18.75% |
| 1998 Q1 | 1.9 Million USD | -5.0% |
| 1998 Q2 | 1.6 Million USD | -15.79% |
| 1998 FY | 1.6 Million USD | -46.67% |
| 1998 Q4 | 2.2 Million USD | 15.79% |
| 1997 Q1 | 2.3 Million USD | 53.33% |
| 1997 FY | 3 Million USD | 114.29% |
| 1997 Q2 | 3 Million USD | 30.43% |
| 1997 Q3 | 3.4 Million USD | 13.33% |
| 1997 Q4 | 2 Million USD | -41.18% |
| 1996 FY | 1.4 Million USD | -6.67% |
| 1996 Q4 | 1.5 Million USD | 15.38% |
| 1996 Q3 | 1.3 Million USD | -7.14% |
| 1996 Q1 | 1.9 Million USD | 0.0% |
| 1996 Q2 | 1.4 Million USD | -26.32% |
| 1995 Q3 | 1.7 Million USD | 13.33% |
| 1995 Q1 | 1.7 Million USD | 0.0% |
| 1995 Q2 | 1.5 Million USD | -11.76% |
| 1995 Q4 | 1.9 Million USD | 11.76% |
| 1995 FY | 1.5 Million USD | -6.25% |
| 1994 Q2 | 1.6 Million USD | 60.0% |
| 1994 Q3 | 1.7 Million USD | 6.25% |
| 1994 FY | 1.6 Million USD | 128.57% |
| 1994 Q1 | 1 Million USD | -23.08% |
| 1994 Q4 | 1.7 Million USD | 0.0% |
| 1993 Q4 | 1.3 Million USD | 8.33% |
| 1993 Q2 | 700 Thousand USD | -22.22% |
| 1993 Q1 | 900 Thousand USD | 28.57% |
| 1993 FY | 700 Thousand USD | 40.0% |
| 1993 Q3 | 1.2 Million USD | 71.43% |
| 1992 FY | 500 Thousand USD | -28.57% |
| 1992 Q2 | 500 Thousand USD | -37.5% |
| 1992 Q4 | 700 Thousand USD | 0.0% |
| 1992 Q1 | 800 Thousand USD | 14.29% |
| 1992 Q3 | 700 Thousand USD | 40.0% |
| 1991 Q4 | 700 Thousand USD | -30.0% |
| 1991 FY | 700 Thousand USD | -53.33% |
| 1991 Q3 | 1 Million USD | 42.86% |
| 1991 Q2 | 700 Thousand USD | -61.11% |
| 1991 Q1 | 1.8 Million USD | 20.0% |
| 1990 Q2 | 1.5 Million USD | -97.06% |
| 1990 Q1 | 51.1 Million USD | -0.97% |
| 1990 FY | 1.5 Million USD | -11.76% |
| 1990 Q4 | 1.5 Million USD | 0.0% |
| 1990 Q3 | 1.5 Million USD | 0.0% |
| 1989 Q3 | 1.9 Million USD | 11.76% |
| 1989 FY | 1.7 Million USD | 54.55% |
| 1989 Q2 | 1.7 Million USD | 0.0% |
| 1989 Q4 | 51.6 Million USD | 2615.79% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -97.374% |
| BrainsWay Ltd. | 15.31 Million USD | -560.585% |
| Cerus Corporation | 144.3 Million USD | 29.897% |
| Envoy Medical, Inc. | 9.4 Million USD | -975.963% |
| electroCore, Inc. | 8.94 Million USD | -1030.933% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -1793.71% |
| IceCure Medical Ltd | 4.24 Million USD | -2281.964% |
| Inogen, Inc. | 121.38 Million USD | 16.658% |
| OrthoPediatrics Corp. | 72.56 Million USD | -39.416% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -241.983% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -3079.252% |
| MaxCyte, Inc. | 36.1 Million USD | -180.173% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -5374.401% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -23687.096% |
| Orthofix Medical Inc. | 326.58 Million USD | 69.024% |
| PAVmed Inc | 57.13 Million USD | -77.052% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -297.29% |
| RxSight, Inc. | 22.18 Million USD | -355.931% |
| Sight Sciences, Inc. | 46.43 Million USD | -117.853% |
| SI-BONE, Inc. | 61.05 Million USD | -65.704% |
| TELA Bio, Inc. | 59.16 Million USD | -70.977% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 11.237% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -880.347% |
| Acutus Medical, Inc. | 54.83 Million USD | -84.471% |
| Talis Biomedical Corporation | 29.22 Million USD | -246.161% |
| Spectral AI, Inc. | 12.4 Million USD | -715.757% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -337.287% |
| CVRx, Inc. | 39.28 Million USD | -157.528% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -745.972% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -4064.245% |
| Bioventus Inc. | 589.79 Million USD | 82.848% |
| Venus Concept Inc. | 107.1 Million USD | 5.547% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -95.811% |
| LivaNova PLC | 1.15 Billion USD | 91.218% |
| 908 Devices Inc. | 37.49 Million USD | -169.837% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 85.62% |
| Nemaura Medical Inc. | 26.37 Million USD | -283.517% |
| NeuroPace, Inc. | 86.99 Million USD | -16.282% |
| LENSAR, Inc. | 22.4 Million USD | -351.435% |
| Apyx Medical Corporation | 52.31 Million USD | -93.36% |
| Cutera, Inc. | 518.12 Million USD | 80.475% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -244.933% |
| BioSig Technologies, Inc. | 4.68 Million USD | -2059.274% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -73.321% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -370.784% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 95.389% |
| Axonics, Inc. | 82.35 Million USD | -22.831% |
| Outset Medical, Inc. | 190.91 Million USD | 47.012% |
| IRIDEX Corporation | 24.91 Million USD | -306.045% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 18.395% |
| IRadimed Corporation | 20.73 Million USD | -387.858% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -5943.13% |
| INVO Bioscience, Inc. | 19.99 Million USD | -405.937% |
| Telesis Bio, Inc. | 40.87 Million USD | -147.503% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -148.005% |
| Varex Imaging Corporation | 668.6 Million USD | 84.87% |
| Quipt Home Medical Corp. | 136.29 Million USD | 25.776% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -2732.083% |
| Pulmonx Corporation | 60.63 Million USD | -66.835% |
| Dynatronics Corporation | 11.78 Million USD | -758.752% |
| Modular Medical, Inc. | 2.27 Million USD | -4352.553% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -2389.222% |
| Semler Scientific, Inc. | 6.27 Million USD | -1513.429% |
| InMode Ltd. | 75.91 Million USD | -33.259% |
| Bruker Corporation | 2.83 Billion USD | 96.434% |
| Cytosorbents Corporation | 29.98 Million USD | -237.37% |
| DexCom, Inc. | 4.19 Billion USD | 97.589% |
| Align Technology, Inc. | 2.45 Billion USD | 95.877% |
| Viveve Medical, Inc. | 10.84 Million USD | -832.627% |
| ZimVie Inc. | 795.85 Million USD | 87.289% |
| Movano Inc. | 5.97 Million USD | -1593.938% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 3.291% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -23687.096% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -745.972% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 84.169% |
| Profound Medical Corp. | 12.66 Million USD | -698.698% |
| Insulet Corporation | 1.85 Billion USD | 94.548% |
| enVVeno Medical Corporation | 2.43 Million USD | -4054.497% |
| Surmodics, Inc. | 65.82 Million USD | -53.688% |
| iCAD, Inc. | 8 Million USD | -1164.367% |
| Nuwellis, Inc. | 6.78 Million USD | -1392.065% |
| Biotricity, Inc. | 35.91 Million USD | -181.636% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 54.645% |
| Aethlon Medical, Inc. | 2.47 Million USD | -3979.689% |
| InspireMD, Inc. | 8.14 Million USD | -1142.471% |
| PAVmed Inc. | 57.13 Million USD | -77.052% |
| BIOLASE, Inc. | 35.34 Million USD | -186.189% |
| Beyond Air, Inc. | 29.77 Million USD | -239.755% |
| FONAR Corporation | 57.45 Million USD | -76.064% |
| Vivani Medical, Inc. | 25.03 Million USD | -304.066% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -15.224% |
| Inari Medical, Inc. | 209.32 Million USD | 51.672% |
| UFP Technologies, Inc. | 118.04 Million USD | 14.302% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -697.148% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -4528.12% |
| Tenon Medical, Inc. | 5.56 Million USD | -1717.173% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -5586.453% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -473.672% |
| AdaptHealth Corp. | 3.15 Billion USD | 96.792% |
| Sintx Technologies, Inc. | 6.59 Million USD | -1434.385% |
| NanoVibronix, Inc. | 2.68 Million USD | -3666.27% |
| Quanterix Corporation | 78.08 Million USD | -29.555% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -2732.083% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -1970.87% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 90.317% |
| TransMedics Group, Inc. | 568.84 Million USD | 82.216% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -506.414% |
| NeuroMetrix, Inc. | 1.33 Million USD | -7488.341% |
| Hyperfine, Inc. | 9.8 Million USD | -932.265% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 59.575% |
| Biomerica, Inc. | 2.66 Million USD | -3698.798% |
| Bone Biologics Corporation | 831.4 Thousand USD | -12067.64% |
| AVITA Medical, Inc. | 19.86 Million USD | -409.237% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -5025.544% |
| Silk Road Medical, Inc | 114.15 Million USD | 11.384% |